Biogen (BIIB) reported 3rd Quarter September 2020 earnings of $8.84 per share on revenue of $3.4 billion. The consensus earnings estimate was $8.06 per share on revenue of $3.4 billion. The Earnings Whisper number was $8.40 per share. Revenue fell 6.2% compared to the same quarter a year ago.
Biogen Idec Inc, is a biopharmaceutical company. The Company discovers,
develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.